[Steroids in the critical care children with septic shock and other conditions]

F Ughetto1, O Paut, C Mareau

  • 1Département d'anesthésie et de réanimation pédiatrique, CHU Timone-Enfants et université de la Méditerranée, faculté de médecine, Marseille cedex 05, France.

Insights

Steroids in pediatric intensive care have varied uses, but evidence for their benefit in pediatric septic shock is lacking. However, steroids can improve outcomes in neonates after cardiac surgery and in treating croup and bacterial meningitis.

Area of Science:

  • Pediatric Intensive Care Medicine
  • Pediatric Pharmacology
  • Pediatric Critical Care

Context:

  • Steroids are used in pediatric intensive care for anti-inflammatory and substitutive purposes.
  • Adrenal insufficiency (AI) incidence in pediatric septic shock ranges from 18-52%.
  • Unlike adults, pediatric septic shock lacks sufficient evidence for steroid benefits on outcomes.

Purpose:

  • To review the current evidence and indications for steroid use in pediatric intensive care.
  • To evaluate the efficacy and safety of steroids in various pediatric critical conditions.
  • To provide guidance on appropriate steroid dosing and application in neonates and children.

Summary:

  • In neonates, steroids improve hemodynamics post-cardiac surgery (30-100 mg/m²/d hydrocortisone).
  • Dexamethasone reduces stridor and reintubation in neonates and infants, and improves croup symptoms.
  • Steroids are indicated for severe asthma and bacterial meningitis, improving neurological outcomes and reducing mortality.

Impact:

  • Steroid use in pediatric septic shock requires further investigation due to lack of demonstrated outcome benefits.
  • Steroids are beneficial in specific neonatal and pediatric conditions like post-cardiac surgery, croup, and meningitis.
  • Potential central nervous system side effects limit steroid use in bronchopulmonary dysplasia.

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...